Cancer news
Latest news, press releases and blog posts from Cancer Research UK.
Melanoma
Smoking may limit body’s ability to fight dangerous form of skin cancer
Melanoma patients with a history of smoking cigarettes are 40 per cent less likely to survive their skin cancer than people who have never smoked
Skin cancer can spread in mice by hijacking the immune system
Scientists have uncovered molecules released by invasive skin cancer that reprogram healthy immune cells to help the cancer to spread.
Immunotherapy drug made available for some NHS patients with advanced skin cancer after surgery
An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England.
Immunotherapy drug to be made available for some NHS patients with advanced skin cancer
Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England.
Drug combo for advanced skin cancer approved on NHS in England
Patients with a certain type of aggressive skin cancer will now have access to a combination of targeted drugs on the NHS in England.
Blood test could predict skin cancer's return
Scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.
Gut bacteria may influence response to cancer immunotherapy
The type of bacteria in the gut of patients with advanced melanoma may influence their response to a certain type immunotherapy, according to new research.
Meet our scientists investigating cancers’ weak spots, showing research ROCKs, and much more
We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.
Immunotherapy and targeted drugs could stop some melanomas from returning
Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease.
Viruses may boost immunotherapy success
Viruses may improve the success rate of immunotherapy treatments, according to two new studies.